The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass*

Abstract

rFVIIa may be useful in preventing reexploration in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Randomized, placebo-controlled studies are needed to confirm the safety and efficacy of rFVIIa in this clinical setting.

References

Page 1

	Year	Citations
Platelet activity of high‐dose factor VIIa is independent of tissue factor Dougald M. Monroe, Maureane Hoffman, Julie A. Oliver, British Journal of Haematology	1997	538
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations Michael J. Moulton, Lawrence L. Creswell, Mary E. Mackey, Journal of Thoracic and Cardiovascular Surgery ThrombosisCardiac AnaesthesiaCardiovascular DiseasePatient SafetyAdverse Outcomes	1996	426
Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children KW Hedberg, HC Kim, GR Bunin, Blood	1991	308
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery Andreas Laupacis, Dean Fergusson Anesthesia & Analgesia Transfusion ThresholdCardiac AnaesthesiaPerioperative MedicineSurgeryPharmacotherapy	1997	300
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery M. Al Douri, Tariq Shafi, D. Al Khudairi, Blood Coagulation & Fibrinolysis	2000	174
An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII Herman G. D. Hendriks, Joost M. van der Maaten, Joost de Wolf, Anesthesia & Analgesia	2001	145
An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII Herman G. D. Hendriks, Joost M. van der Maaten, Joost de Wolf, Anesthesia & Analgesia Adult Cardiac SurgerySurgerySevere Intractable BleedingThrombosisValve Repair	2001	95
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant Joseph D. Tobias, John W. Berkenbosch, Pierantonio Russo Pediatric Critical Care Medicine	2003	93
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta Marc Kastrup, Christian von Heymann, Holger Hotz, The Annals of Thoracic Surgery Heart FailureAortic Valve ReplacementRecombinant Factor ViiaValve DiseaseCongenital Heart Defect	2002	52
Preliminary Experience with the Use of Recombinant Factor VIIa to Treat Coagulation Disturbances in Pediatric Patients Joseph D. Tobias, Kelly Groeper, John W. Berkenbosch Southern Medical Journal	2003	45

Page 1